| Lasa Supergenerics Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540702 |
NSE Symbol : LASA |
P/E(TTM) : - |
|
ISIN Demat : INE670X01014 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 18.11 |
Market Cap(₹Cr) : 138.53 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 39.39 | 30.84 | 22.82 | 26.66 | 24.30 | 30.56 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 39.39 | 30.84 | 22.82 | 26.66 | 24.30 | 30.56 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.95 | 0.00 | 0.01 | 0.00 | 0.08 | 0.00 |
| Total Income | 41.34 | 30.84 | 22.82 | 26.66 | 24.39 | 30.56 |
| Total Expenditure | 38.60 | 29.04 | 35.57 | 25.61 | 23.26 | 26.51 |
| PBIDT | 2.74 | 1.80 | -12.75 | 1.06 | 1.13 | 4.05 |
| Interest | 1.24 | 0.87 | 0.56 | 0.44 | 0.56 | 0.37 |
| PBDT | 1.50 | 0.93 | -13.31 | 0.62 | 0.57 | 3.68 |
| Depreciation | 2.81 | 2.79 | 2.66 | 2.68 | 2.68 | 2.65 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.92 | 0.87 | -0.67 | -0.61 | -2.09 | 5.98 |
| Reported Profit After Tax | -3.23 | -2.73 | -15.30 | -1.46 | -0.02 | -4.95 |
| Extra-ordinary Items | 0.00 | 0.00 | -8.77 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -3.23 | -2.73 | -6.53 | -1.46 | -0.02 | -4.95 |
| EPS (Unit Curr.) | -0.64 | -0.55 | -3.05 | -0.29 | 0.00 | -0.99 |
| EPS (Adj) (Unit Curr.) | -0.64 | -0.55 | -3.05 | -0.29 | 0.00 | -0.99 |
| Calculated EPS (Unit Curr.) | -0.64 | -0.55 | -3.05 | -0.29 | 0.00 | -0.99 |
| Calculated EPS (Adj) (Unit Curr.) | -0.64 | -0.55 | -3.05 | -0.29 | 0.00 | -0.99 |
| Calculated EPS (Ann.) (Unit Curr.) | -2.58 | -2.18 | -12.22 | -1.16 | -0.02 | -3.95 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -2.58 | -2.18 | -12.22 | -1.16 | -0.02 | -3.95 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 50.10 | 50.10 | 50.10 | 50.10 | 50.10 | 50.10 |
| Reserve & Surplus | 40.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.96 | 5.84 | -55.87 | 3.98 | 4.65 | 13.25 |
| PBDTM(%) | 3.81 | 3.02 | -58.33 | 2.33 | 2.35 | 12.04 |
| PATM(%) | -8.20 | -8.85 | -67.05 | -5.48 | -0.08 | -16.20 |